SCHEMBL8806840

SCHEMBL8806840

COc1ccc(CN(C)CCc2ccc(NC(=O)c3cccc(C(=O)c4ccccc4)c3)cc2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 8/20 0.56
▸ BCHE P06276 5/20 0.56
▸ CYP3A4 P08684 2/20 0.53
▸ ROCK2 O75116 2/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ KDM4E B2RXH2 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ BLM P54132 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ MCHR1 Q99705 1/20 0.52
▸ OPRM1 P35372 1/20 0.51
▸ TMEM97 Q5BJF2 1/20 0.51
▸ SIGMAR1 Q99720 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ ABCB1 P08183 1/20 0.48
▸ ABCG2 Q9UNQ0 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8807451 0.88 ACHE (0.55) ACHEBCHECYP3A4ROCK2MEN1
SCHEMBL8806850 0.86 MEN1 (0.53) ACHEBCHECYP3A4ROCK2MEN1
SCHEMBL4048156 0.81 BCHE (0.54) ACHEBCHECYP3A4MEN1KMT2A
SCHEMBL4048160 0.80 ABCB1 (0.58) ACHEBCHECYP3A4MEN1KMT2A
SCHEMBL8806857 0.79 MEN1 (0.48) ACHEBCHECYP3A4ROCK2MEN1
SCHEMBL8807326 0.78 BCHE (0.47) ACHEBCHECYP3A4ROCK2MEN1
SCHEMBL514870 0.77 KMT2A (0.82) ACHEBCHECYP3A4MEN1KMT2A
SCHEMBL8812228 0.76 ACHE (0.56) ACHEBCHEMEN1KMT2AKDM4E
SCHEMBL8807941 0.76 ABCB1 (0.57) ACHEBCHEMEN1KMT2AKDM4E
SCHEMBL8809414 0.75 ACHE (0.62) ACHEBCHEMEN1KMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback